Oxeia Biopharmaceuticals develops novel therapeutics for patients with concussions.

Because rest is not enough

Join the mission to bring the first FDA-approved treatment for persistent concussion symptoms to market. Visit our campaign page.

What’s New…

Oxeia Biopharma In the News

US Navy Rear Admiral Don Plummer Joins Oxeia Biopharmaceuticals Advisory Board as Military Concussions Remain a Critical National Health Challenge

Global Award honors excellence, resilience & innovation in healthcare & pharmaceuticals for outstanding contribution to driving progress in concussion care

Oxeia Biopharmaceuticals is a team of passionate scientists, biotech leaders, and athletes dedicated to bringing a safe and effective concussion therapy to market.

REST IS NOT ENOUGH.

More About What We Do